ALEXANDRA QUINN: Open Payments
NPI 1821530825 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,713 in 120 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $444 · 2025 $2,713
Food & beverage: $2,629Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $461 |
| ABBVIE INC. | 16 | $332 |
| Madrigal Pharmaceuticals | 11 | $320 |
| Phathom Pharmaceuticals, Inc. | 13 | $265 |
| Ardelyx, Inc. | 14 | $263 |
| Lilly USA, LLC | 11 | $239 |
| GENZYME CORPORATION | 6 | $158 |
| Ipsen Biopharmaceuticals, Inc | 6 | $136 |
| Regeneron Healthcare Solutions, Inc. | 5 | $90 |
| QOL Medical, LLC | 4 | $84 |
Products named: TREMFYA, REZDIFFRA, VOQUEZNA, IBSRELA, DUPIXENT, OMVOH, IQIRVO, CREON.
Industry payments across DE — which companies pay providers there.
